Tumor-suppressing functions of CAFs were reported in pancreatic cancer, in which targeting the believed pro-tumor hedgehog signaling pathway in CAFs, or genetic depletion of αSMA+ CAFs from tumors unexpectedly enhanced tumor progression. This evidence concerns the gene ACTA1 and familial pancreatic carcinoma.